BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18550831)

  • 21. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
    Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
    J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].
    Stanic AK; Shashidharamurthy R; Bezbradica JS; Matsuki N; Yoshimura Y; Miyake S; Choi EY; Schell TD; Van Kaer L; Tevethia SS; Roopenian DC; Yamamura T; Joyce S
    J Immunol; 2003 Nov; 171(9):4539-51. PubMed ID: 14568927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.
    Lang GA; Devera TS; Lang ML
    Blood; 2008 Feb; 111(4):2158-62. PubMed ID: 18077787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Lang GA; Exley MA; Lang ML
    Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vivo response of invariant natural killer T cells to glycolipid antigens.
    Parekh VV; Lalani S; Van Kaer L
    Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.
    Tonti E; Fedeli M; Napolitano A; Iannacone M; von Andrian UH; Guidotti LG; Abrignani S; Casorati G; Dellabona P
    J Immunol; 2012 Apr; 188(7):3217-22. PubMed ID: 22379027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
    Patterson S; Chaidos A; Neville DC; Poggi A; Butters TD; Roberts IA; Karadimitris A
    J Immunol; 2008 Sep; 181(5):3268-76. PubMed ID: 18713998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and functional analysis of mouse invariant natural T (iNKT) cells.
    Bezbradica JS; Stanic AK; Joyce S
    Curr Protoc Immunol; 2006 Jul; Chapter 14():14.13.1-14.13.27. PubMed ID: 18432968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invariant NKT cells sustain specific B cell responses and memory.
    Galli G; Pittoni P; Tonti E; Malzone C; Uematsu Y; Tortoli M; Maione D; Volpini G; Finco O; Nuti S; Tavarini S; Dellabona P; Rappuoli R; Casorati G; Abrignani S
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3984-9. PubMed ID: 17360464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
    J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.
    Matsuda JL; Mallevaey T; Scott-Browne J; Gapin L
    Curr Opin Immunol; 2008 Jun; 20(3):358-68. PubMed ID: 18501573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune responses support adaptive immunity: NKT cells induce B cell activation.
    Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
    Vaccine; 2003 Jun; 21 Suppl 2():S48-54. PubMed ID: 12763683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A closer look at CD1d molecules: new horizons in studying NKT cells.
    Stronge VS; Salio M; Jones EY; Cerundolo V
    Trends Immunol; 2007 Oct; 28(10):455-62. PubMed ID: 17825624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity.
    Campos RA; Szczepanik M; Itakura A; Akahira-Azuma M; Sidobre S; Kronenberg M; Askenase PW
    J Exp Med; 2003 Dec; 198(12):1785-96. PubMed ID: 14676294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
    Lawson V
    Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro.
    Zeng SG; Ghnewa YG; O'Reilly VP; Lyons VG; Atzberger A; Hogan AE; Exley MA; Doherty DG
    J Immunol; 2013 Aug; 191(4):1666-76. PubMed ID: 23851681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.